Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://link.springer.com/article/10.1007/s12275-020-0375-y, but it redirected us to https://link.springer.com/article/10.1007/s12275-020-0375-y. The analysis below is for the second page.

Title[redir]:
Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression | Journal of Microbiology
Description:
Lactobacillus plantarum-derived metabolites (LDMs) increase drug sensitivity to 5-FU and antimetastatic effects in 5-FU-resistant colorectal cancer cells (HCT-116/5FUR). In this study, we evaluated the effects of LDMs on the regulation of genes and proteins involved in HCT-116/5-FUR cell proliferation and metastasis. HCT-116/5-FUR cells showed high metastatic potential, significantly reduced tight junction (TJ) integrity, including increased migration and paracellular permeability, and upregulation of claudin-1 (CLDN-1). The genetic silencing of CLDN-1 increased the sensitivity of HCT-116/5FUR to 5-FU and inhibited its metastatic potential by regulating the expression of epithelial-mesenchymal transition (EMT) related genes. Co-treatment of HCT-116/5FUR with LDMs and 5-FU suppressed chemoresistant and metastatic behavior by downregulating CLDN-1 expression. Finally, we designed LDMs-based therapeutic strategies to treatment for metastatic 5-FU-resistant colorectal cancer cells. These results suggested that LDMs and 5-FU cotreatments can synergistically target 5-FU-resistant cells, making it a candidate strategy to overcome 5-FU chemoresistance improve anticancer drug efficacy.

Matching Content Categories {πŸ“š}

  • Education
  • Health & Fitness
  • Science

Content Management System {πŸ“}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {πŸ’Έ}

We don’t know how the website earns money.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Doi.org could be secretly minting cash, but we can't detect the process.

Keywords {πŸ”}

pubmed, article, google, scholar, cancer, cas, colorectal, central, cells, claudin, lactobacillus, metastatic, expression, tight, junction, intestinal, colon, effects, fluorouracil, gut, plantarum, singh, physiol, microbiota, research, furesistant, proteins, cell, cldn, access, microbiol, barrier, dhawan, human, privacy, cookies, function, content, journal, metabolites, behavior, hctfur, metastasis, gastroenterol, sharma, information, publish, search, regulating, ldms,

Topics {βœ’οΈ}

month download article/chapter lactobacillus-derived metabolites enhance hct-116/5-fur cell proliferation 5-fu suppressed chemoresistant ct26 tumour-bearing mice targeting chemotherapy-induced cldn1 host-microbe interaction published inhibit e-cadherin expression combination therapy epithelial-mesenchymal transition gut-heart-brain axis anti-tumour immune effect related subjects colorectal cancer cells full article pdf colorectal adenocarcinoma cells tight junction formation colon cancer cells tight junction proteins eun-mi ha metastatic colorectal cancer tight junction permeability privacy choices/manage cookies human intestinal microbiome downregulating cldn-1 expression lactobacillus plantarum supernatant colorectal cancer statistics human developmental biology fluorouracil-induced neurotoxicity inhibit metastatic behavior national research foundation check access instant access colorectal cancer incidence tumor-suppressive effects european economic area increase drug sensitivity 5-fluouracil increases chemosensitivity multicentre randomised trial early life shapes probiotic therapy inflammatory bowel diseases lasting commensal relationship sulfide-detoxifying enzymes article journal metastatic potential including increased migration regulating claudin-1 expression conditions privacy policy tumor metastasis

Questions {❓}

  • Intestinal microbiota development in the premature neonate: Establishment of a lasting commensal relationship?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression
         description:Lactobacillus plantarum-derived metabolites (LDMs) increase drug sensitivity to 5-FU and antimetastatic effects in 5-FU-resistant colorectal cancer cells (HCT-116/5FUR). In this study, we evaluated the effects of LDMs on the regulation of genes and proteins involved in HCT-116/5-FUR cell proliferation and metastasis. HCT-116/5-FUR cells showed high metastatic potential, significantly reduced tight junction (TJ) integrity, including increased migration and paracellular permeability, and upregulation of claudin-1 (CLDN-1). The genetic silencing of CLDN-1 increased the sensitivity of HCT-116/5FUR to 5-FU and inhibited its metastatic potential by regulating the expression of epithelial-mesenchymal transition (EMT) related genes. Co-treatment of HCT-116/5FUR with LDMs and 5-FU suppressed chemoresistant and metastatic behavior by downregulating CLDN-1 expression. Finally, we designed LDMs-based therapeutic strategies to treatment for metastatic 5-FU-resistant colorectal cancer cells. These results suggested that LDMs and 5-FU cotreatments can synergistically target 5-FU-resistant cells, making it a candidate strategy to overcome 5-FU chemoresistance improve anticancer drug efficacy.
         datePublished:2020-10-30T00:00:00Z
         dateModified:2020-10-30T00:00:00Z
         pageStart:967
         pageEnd:977
         sameAs:https://doi.org/10.1007/s12275-020-0375-y
         keywords:
            colorectal cancer
            HCT-116
            5-FU
            chemoresistant
             Lactobacillus
            metastasis
            tight junction
            CLDN-1
            combination therapy
            Microbiology
         image:
         isPartOf:
            name:Journal of Microbiology
            issn:
               1976-3794
               1225-8873
            volumeNumber:58
            type:
               Periodical
               PublicationVolume
         publisher:
            name:The Microbiological Society of Korea
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:JaeJin An
               affiliation:
                     name:Medical Convergence Materials Commercialization Center
                     address:
                        name:Medical Convergence Materials Commercialization Center, Gyeongsan, Republic of Korea
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eun-Mi Ha
               affiliation:
                     name:Catholic University of Daegu
                     address:
                        name:Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan, Republic of Korea
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Lactobacillus-derived metabolites enhance the antitumor activity of 5-FU and inhibit metastatic behavior in 5-FU-resistant colorectal cancer cells by regulating claudin-1 expression
      description:Lactobacillus plantarum-derived metabolites (LDMs) increase drug sensitivity to 5-FU and antimetastatic effects in 5-FU-resistant colorectal cancer cells (HCT-116/5FUR). In this study, we evaluated the effects of LDMs on the regulation of genes and proteins involved in HCT-116/5-FUR cell proliferation and metastasis. HCT-116/5-FUR cells showed high metastatic potential, significantly reduced tight junction (TJ) integrity, including increased migration and paracellular permeability, and upregulation of claudin-1 (CLDN-1). The genetic silencing of CLDN-1 increased the sensitivity of HCT-116/5FUR to 5-FU and inhibited its metastatic potential by regulating the expression of epithelial-mesenchymal transition (EMT) related genes. Co-treatment of HCT-116/5FUR with LDMs and 5-FU suppressed chemoresistant and metastatic behavior by downregulating CLDN-1 expression. Finally, we designed LDMs-based therapeutic strategies to treatment for metastatic 5-FU-resistant colorectal cancer cells. These results suggested that LDMs and 5-FU cotreatments can synergistically target 5-FU-resistant cells, making it a candidate strategy to overcome 5-FU chemoresistance improve anticancer drug efficacy.
      datePublished:2020-10-30T00:00:00Z
      dateModified:2020-10-30T00:00:00Z
      pageStart:967
      pageEnd:977
      sameAs:https://doi.org/10.1007/s12275-020-0375-y
      keywords:
         colorectal cancer
         HCT-116
         5-FU
         chemoresistant
          Lactobacillus
         metastasis
         tight junction
         CLDN-1
         combination therapy
         Microbiology
      image:
      isPartOf:
         name:Journal of Microbiology
         issn:
            1976-3794
            1225-8873
         volumeNumber:58
         type:
            Periodical
            PublicationVolume
      publisher:
         name:The Microbiological Society of Korea
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:JaeJin An
            affiliation:
                  name:Medical Convergence Materials Commercialization Center
                  address:
                     name:Medical Convergence Materials Commercialization Center, Gyeongsan, Republic of Korea
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eun-Mi Ha
            affiliation:
                  name:Catholic University of Daegu
                  address:
                     name:Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan, Republic of Korea
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Microbiology
      issn:
         1976-3794
         1225-8873
      volumeNumber:58
Organization:
      name:The Microbiological Society of Korea
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical Convergence Materials Commercialization Center
      address:
         name:Medical Convergence Materials Commercialization Center, Gyeongsan, Republic of Korea
         type:PostalAddress
      name:Catholic University of Daegu
      address:
         name:Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan, Republic of Korea
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:JaeJin An
      affiliation:
            name:Medical Convergence Materials Commercialization Center
            address:
               name:Medical Convergence Materials Commercialization Center, Gyeongsan, Republic of Korea
               type:PostalAddress
            type:Organization
      name:Eun-Mi Ha
      affiliation:
            name:Catholic University of Daegu
            address:
               name:Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan, Republic of Korea
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Medical Convergence Materials Commercialization Center, Gyeongsan, Republic of Korea
      name:Department of Pharmacology, College of Pharmacy, Catholic University of Daegu, Gyeongsan, Republic of Korea
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(233)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {πŸ“¦}

  • Crossref

5.31s.